PAR24 COST-UTILITY ANALYSIS OF RITUXIMAB TREATMENT IN RHEUMATOID ARTHRITIS AFTER ANTI-TNF-ALFATHERAPY IN HUNGARY

Nov 1, 2007, 00:00 AM
10.1016/S1098-3015(10)64939-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)64939-X/fulltext
Section Title :
Section Order : 98
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64939-X&doi=10.1016/S1098-3015(10)64939-X
HEOR Topics :
Tags :
Regions :